Bright Academic Experts

Category: Pharmacology

  • Clinical trial data supporting FDA approval of Papzimeos

    Provide me with 5 slides on the clinical trial data supporting FDA approval of Papzimeos, Key Phase II/III trials, Primary endpoints and outcomes, Clinical relevance of trial results, Comparison to existing therapies Advantages and limitations Patient populations most likely to benefit

  • Case Presentation: Transient Ischemic Attack

    The case presentation is composed of these main sections, followed by references:

    1. Case presentation: Components include demographic data, CC, HPI, PMH, FH, SH, allergies, medications prior to admission, ROS, PE, diagnostic studies Labs, Problem list, Daily hospital course (including daily events and monitoring parameters). This section should be no longer than 4 pages. You should insert a table of labs and a table of medications used throughout the hospital course. This can be added as an appendix to the back of the handout and can be up to ten pages in length.
    2. Disease state discussion: Select one of the disease states the patient has and expand upon it. Should include discussion of epidemiology, pathophysiology, clinical presentation, diagnosis. This section should be no longer than two pages in length.
    3. Drug therapy discussion: Should include non-pharmacologic and pharmacologic treatment modalities. Should include first-line as well as alternative treatment options. Should include doses, monitoring parameters (such as adverse effects, drug interactions, etc.) and therapeutic endpoints. Supporting literature should be discussed and referenced when appropriate. This section should be no longer than two pages.
    4. Critique of case presentation: Did the patient receive appropriate therapy for his/her various disease states? Did you make an intervention to optimize therapy? Did you provide counseling to the patient during his/her stay or at discharge? Are there important learning points we can take away from this case? This section should be no longer than one-half page.
    5. References: Provide all references used, listed in proper Index Medicus format, as listed in your Graduation Poster Syllabus

    ADDITIONAL INFO:

    • PLEASE NO AI.
    • USE THE DOCUMENTS ATTACHED FOR MORE INFO ON THE PATIENT CASE
    • YOU MUST FOLLOW THESE SPECIFIC INSTRUCTIONS AND COMPLETE IT BASED ON THE TEMPLATE.
    • THE DOCUMENT LABELED “Case Presentation with Info” IS THE DOCUMENT YOU SHOULD WORK ON AS THAT HAS SOME OF THE INFO ENTERED.

  • Pharmacy School (PharmD)

    1. For Case Studies or Clinical Scenarios

    If you have a patient profile and need to determine drug interactions or side effects:

    • “Clinical Pharmacology: Drug-Drug Interactions in a Geriatric Patient Case Study”
    • “Pharmacotherapy Analysis: Management of Hypertension and Type 2 Diabetes”
    • “Nursing Pharmacology: Adverse Effects of Anticoagulant Therapy Case Analysis”

    2. For Mechanism of Action (MOA) & Basics

    If you are focusing on how a specific class of drugs works at the cellular level:

    • “Mechanism of Action: Comparing Beta-Blockers vs. Calcium Channel Blockers”
    • “Pharmacodynamics & Pharmacokinetics: Analysis of First-Pass Metabolism”
    • “Cellular Pharmacology: Agonist and Antagonist Effects on G-Protein Coupled Receptors”

    3. For Dosage Calculations

    If your assignment is strictly math-based:

    • “Pharmacology Calculations: Pediatric Dosage and IV Flow Rate Problems”
    • “Advanced Medical Math: Reconstitution and Weight-Based Dosing Exercises”

    4. For Research Papers or Essays

    • “Literature Review: The Impact of Opioid Antagonists on Chronic Pain Management”
    • “Pharmacology Essay: The Evolution of Monoclonal Antibody Therapy in Oncology”

    Requirements: